Nanosystems as Drug Delivery Carrier: From Nature to the Medication
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 October 2020) | Viewed by 12462
Special Issue Editor
2. Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain
Interests: drug delivery systems; medicinal chemistry; natural products
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues
In the field of research into nanomedicine, the synthesis of devices of molecular size by using various types of natural polymer like cyclodextrins has been intensively studied from a pharmacological point of view. Thus, research intp the scope of drug delivery systems has been focused on the transport of useful substances and active drugs, which, because of their insolubility in the bloodstream, limit the possibilities of medical treatment in the organism. From the formation of inclusion complexes to the formation of nanoparticles linked to natural or synthetic polymers, suprqamolecular systems have been successful because of their versatility at transporting small substances; their isolation; and their elimination of toxins, heavy elements, and molecules that, due to their physical-chemical characteristics, are difficult to handle in an aqueous environment.
Therefore, the possibility to receive research articles/reviews about the contribution of several drug delivery systems from natural or synthetic sources could help us to understand the importance of choosing nanocapsules, liposomes, or multiples structures to carry drugs under chemical effects in living systems.
Prof. Dr. Eduardo Sobarzo-Sánchez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery systems,
- cyclodextrin,
- nanomedicine,
- active drugs,
- bioavailability
